Perbedaan Merck Tbk. dan Abadi Lestari Indonesia Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Abadi Lestari Indonesia Tbk. diperdagangkan di Rp3.300 (kapitalisasi pasar 10,19 T, volume 24 jam 593,9 rb). Perbedaan utamanya: Abadi Lestari Indonesia Tbk. jauh lebih besar — sekitar 6× kapitalisasi pasar Merck Tbk., dan Abadi Lestari Indonesia Tbk. lebih aktif diperdagangkan (593,9 rb vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | RLCO | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 10,19 T |
Volume | 37,6 rb | 593,9 rb |
Lot | 376 | 5,94 rb |
Perputaran | 144,47 jt | 1,91 M |
Harga Rata-rata | 3.842,23 | 3.220,03 |
Nilai Transaksi | 144,47 jt | 1,91 M |
Harga Ekuilibrium Indikatif | 3.840 | 3.300 |
Volume Ekuilibrium Indikatif | 7 | 87 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Selengkapnya di halaman RLCO →